** Shares of China's biopharmaceuticals products developer Zai Lab Ltd 9688.HK jump 17.1% to HK$32.5, their highest since March 2023, and on course for the second session of gains
** Stock set for the biggest one-day jump since May 9, 2024; second-biggest gainer on healthcare index .HSCIH, which is trading up 1.4%
** Zai Lab, with current market capitalisation of HK$34.26 bln ($4.41 bln), said its 2024 net product revenue increased 49% y/y to $397.6 mln, while R&D expenses decreased 12% y/y to $234.5 mln and net loss reduced 23% y/y to $257.1 mln
** Hang Seng Commerce & Industry Index .HSNC slips 0.7%, Hang Seng Index .HSI eases 0.6%
** Stock up 49% YTD
($1 = 7.7766 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.